Загрузка...
Chimeric antigen receptors: driving immunology towards synthetic biology
The advent of second generation CARs and the CD19 paradigm have ushered a new therapeutic modality in oncology. In contrast to earlier forms of adoptive cell therapy, which were based on the isolation and expansion of naturally occurring T cells, CAR therapy is based on the design and manufacture of...
Сохранить в:
| Опубликовано в: : | Curr Opin Immunol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520666/ https://ncbi.nlm.nih.gov/pubmed/27372731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.06.004 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|